1. Home
  2. ZBH vs FCNCA Comparison

ZBH vs FCNCA Comparison

Compare ZBH & FCNCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZBH
  • FCNCA
  • Stock Information
  • Founded
  • ZBH 1927
  • FCNCA 1898
  • Country
  • ZBH United States
  • FCNCA United States
  • Employees
  • ZBH N/A
  • FCNCA N/A
  • Industry
  • ZBH Industrial Specialties
  • FCNCA Major Banks
  • Sector
  • ZBH Health Care
  • FCNCA Finance
  • Exchange
  • ZBH Nasdaq
  • FCNCA Nasdaq
  • Market Cap
  • ZBH 20.0B
  • FCNCA 22.8B
  • IPO Year
  • ZBH N/A
  • FCNCA N/A
  • Fundamental
  • Price
  • ZBH $98.79
  • FCNCA $1,772.34
  • Analyst Decision
  • ZBH Buy
  • FCNCA Buy
  • Analyst Count
  • ZBH 18
  • FCNCA 10
  • Target Price
  • ZBH $112.88
  • FCNCA $2,275.00
  • AVG Volume (30 Days)
  • ZBH 1.3M
  • FCNCA 188.4K
  • Earning Date
  • ZBH 11-05-2025
  • FCNCA 10-23-2025
  • Dividend Yield
  • ZBH 0.97%
  • FCNCA 0.44%
  • EPS Growth
  • ZBH N/A
  • FCNCA N/A
  • EPS
  • ZBH 4.11
  • FCNCA 169.70
  • Revenue
  • ZBH $7,833,800,000.00
  • FCNCA $8,984,000,000.00
  • Revenue This Year
  • ZBH $8.18
  • FCNCA $0.56
  • Revenue Next Year
  • ZBH $5.91
  • FCNCA $2.24
  • P/E Ratio
  • ZBH $24.10
  • FCNCA $10.43
  • Revenue Growth
  • ZBH 4.11
  • FCNCA N/A
  • 52 Week Low
  • ZBH $89.22
  • FCNCA $1,473.62
  • 52 Week High
  • ZBH $114.72
  • FCNCA $2,412.93
  • Technical
  • Relative Strength Index (RSI)
  • ZBH 44.82
  • FCNCA 35.36
  • Support Level
  • ZBH $96.06
  • FCNCA $1,722.27
  • Resistance Level
  • ZBH $101.31
  • FCNCA $1,789.37
  • Average True Range (ATR)
  • ZBH 2.16
  • FCNCA 46.50
  • MACD
  • ZBH -0.19
  • FCNCA -7.42
  • Stochastic Oscillator
  • ZBH 35.06
  • FCNCA 25.61

About ZBH Zimmer Biomet Holdings Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

About FCNCA First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through its extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

Share on Social Networks: